APA (7th ed.) Citation

Wanner, C., Cooper, M. E., Johansen, O. E., Toto, R., Rosenstock, J., McGuire, D. K., . . . Perkovic, V. (2021). Erratum to: Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes (t2d): the carmelina randomised controlled trial. Clinical Kidney Journal, 14(9), 2136. https://doi.org/10.1093/ckj/sfab104

Chicago Style (17th ed.) Citation

Wanner, Christoph, et al. "Erratum to: Effect of Linagliptin Versus Placebo on Cardiovascular and Kidney Outcomes in Nephrotic-range Proteinuria and Type 2 Diabetes (t2d): The Carmelina Randomised Controlled Trial." Clinical Kidney Journal 14, no. 9 (2021): 2136. https://doi.org/10.1093/ckj/sfab104.

MLA (9th ed.) Citation

Wanner, Christoph, et al. "Erratum to: Effect of Linagliptin Versus Placebo on Cardiovascular and Kidney Outcomes in Nephrotic-range Proteinuria and Type 2 Diabetes (t2d): The Carmelina Randomised Controlled Trial." Clinical Kidney Journal, vol. 14, no. 9, 2021, p. 2136, https://doi.org/10.1093/ckj/sfab104.